UK Healthcare Gazette
SEE OTHER BRANDS

Your healthcare and wellness news from the United Kingdom

UK Healthcare Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.

Press releases published on May 20, 2025

Breast Biopsy Devices Market to Reach USD 4.21 Billion by 2035 at a CAGR of 5.5% | FMI

Breast Biopsy Devices Market to Reach USD 4.21 Billion by 2035 at a CAGR of 5.5% | FMI

Insightful analysis of the Breast Biopsy Devices industry, highlighting market trends, innovations, and growth opportunities worldwide NEWARK, DE, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- The global breast biopsy devices market is projected to …

Global Softgel Capsules Market Poised for Steady Growth to Reach USD 2,172 Million by 2035

Global Softgel Capsules Market Poised for Steady Growth to Reach USD 2,172 Million by 2035

Rising demand for enhanced bioavailability and consumer preference for softgel delivery fuels robust growth in the global softgel capsules market NEWARK, DE, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- The global Softgel Capsules Market is …

Proteomics Market Poised for Significant Growth, Projected to Reach USD 134.82 Billion by 2035 at a CAGR of 11.7% | FMI

Proteomics Market Poised for Significant Growth, Projected to Reach USD 134.82 Billion by 2035 at a CAGR of 11.7% | FMI

Proteomics Market poised for robust growth, driven by advances in protein research, biomarker discovery, and increasing pharmaceutical applications worldwide NEWARK, DE, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- The global proteomics market is …

Cardiac Ambulatory Monitoring Market is expected to reach USD 21.6 Billion by 2032 at a CAGR of 4.5% | FMI

Cardiac Ambulatory Monitoring Market is expected to reach USD 21.6 Billion by 2032 at a CAGR of 4.5% | FMI

Global Cardiac Ambulatory Monitoring Market set to grow significantly, driven by rising cardiovascular diseases and advancements in monitoring technologies NEWARK, DE, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- As per Future Market Insights’ …

Teeth Whitening Treatments in Emerging Market is projected to hit USD 10,766.7 Million by 2034 a CAGR of 4.10% | FMI

Teeth Whitening Treatments in Emerging Market is projected to hit USD 10,766.7 Million by 2034 a CAGR of 4.10% | FMI

Global Teeth Whitening Market Surges with Rising Aesthetic Awareness, Innovations in At-Home Kits, and Expanding Demand from Emerging Economies. NEWARK, DE, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- The teeth whitening market is likely to be …

'Resonance of the Soul - Flowers and Harmonics: A Poetic Journey' - By Dr. Ivan Edwards

'Resonance of the Soul - Flowers and Harmonics: A Poetic Journey' - By Dr. Ivan Edwards

"A poetic exploration of love, healing, justice, environmental awareness, human growth, and life’s deepest reflections. SAN ANTONIO, TX, UNITED STATES, May 20, 2025 /⁨EINPresswire.com⁩/ -- Dr. Ivan Edwards, CEO and Founder of Jovana Rehabilitation …

Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant depression

Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant depression

Positive results show that a single dose of BPL-003, administered adjunctively to SSRIs, produced a rapid and long-lasting antidepressant effect for up to three months after dosing. BPL-003 was well-tolerated and patients were able to be discharged within …

Actimed Therapeutics Announces New Programme to Investigate Potential Muscle Preservation Effects of S-pindolol Benzoate in Obese Patients Treated with GLP-1 Agonists

Actimed Therapeutics Announces New Programme to Investigate Potential Muscle Preservation Effects of S-pindolol Benzoate in Obese Patients Treated with GLP-1 Agonists

Two-part preclincal and clinical development programme launched to assess potential benefits of administering S-pindolol benzoate during and post-GLP-1 receptor agonist therapy to improve muscle mass, cardiac protection and bone mineral density in obese …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service